Page 391 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Ophthalmologic and Neuro-Ophthalmologic Aspects of Vasculitides 365

[121] Jordan N, Verma H, Ekbote A. Dacryoadenitis and diffuse orbital inflammation:
unusual first presentation of Churg-Strauss syndrome. Orbit, 2011; 30:160-161.

[122] Bosch X, Guilabert A, Espinosa G, et al. Treatment of antineutrophil cytoplasmic
antibody associated vasculitis: a systematic review. JAMA, 2007; 298:655-669.

[123] Moosig F, Bremer JP, Hellmich B, et al. A vasculitis centre based management strategy
leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-
Strauss, EGPA): monocentric experiences in 150 patients. Ann. Rheum. Dis., 2013;
72:1011-1017.

[124] Watts R, Jolliffe V, Carruthers D, et al. Effect of classification on the incidence of
polyarteritis nodosa and microscopic polyangiitis. Arthritis and Rheum. 1996; 39:1208-
1212.

[125] Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis. Clinical
and laboratory findings in eighty-five patients. Arthritis and Rheum. 1999; 42:421-430.

[126] Jennette JC, Thomas DB, Falk RJ. Microscopic polyangiitis (microscopic polyarteritis).
Semin. Diagn Pathol., 2001; 18:3-13.

[127] Hara A, Ohta S, Takata M, et al. Microscopic polyangiitis with ocular manifestations as
the initial presenting sign. Am. J. Med. Sci., 2007; 334: 308-310.

[128] Savage C, Winearls CG, Evans DJ, et al. Microscopic polyarteritis: presentation,
pathology and prognosis. Quarterly Journal of Medicine, 56:467-483.

[129] Altaie R, Ditzio F, Fahy GT. Microscopic polyangitis presenting with sub-acute
reversible optic neuropathy. Eye, 2005; 19:363-365.

[130] Darlington JK, Mannis MJ, Segal WA, et al. Peripheral nonulcerative keratitis as a
presenting sign of microscopic polyangiitis. Cornea, 2001; 20:522-524.

[131] Alrashidi S, Yousef Y, Krema H. Visual loss from scleritis in C-ANCA positive
microscopic polyangiitis. BMJ Case Reports, 2013: June 10.

[132] Villiger P, Guillevin L. Microscopic polyangiitis: Clinical presentation. Autoimmunity
Reviews, 2010; 9:812-819.

[133] Corral-Gudino L, Borao-Cengotita-Bengoa M, Del Pino-Montes J, et al. Overall
survival, renal survival and relapse in patients with microscopic polyangiitis: a
systematic review of current evidence. Rheumatology, 2011; 50:1414-1423.

[134] Mihara M, Hayasaka S, Watanabe K, et al. Ocular manifestations in patients with
microscopic polyangiitis. Eur. J. Ophthalmol., 2004; 15:138-142.

[135] Grotz W, Baba H, Becker J, et al. Hypocomplementemic urticarial vasculitis syndrome.
An interdisciplinary challenge. Dtsch. Arztebl. Int., 2009; 106:756-763.

[136] Mehregan D, Hall M, Gibson L. Urticarial vasculitis: a histopathologic and clinical
review of 72 cases. J. Am. Acad. Dermatol., 1992; 26:441-448.

[137] Schwartz HR, McDuffie FC, Black LF, et al. Hypocomplementemic urticarial
vasculitis: association with chronic obstructive pulmonary disease. Mayo Clin. Proc.,
1982; 57:231-238.

[138] Wisnieski JJ, Baer AN, Christensen J, et al. Hypocomplementemic urticarial vasculitis
syndrome: clinical and serologic findings in 18 patients. Medicine (Baltimore), 1995;
74:24-41.

[139] Davis M, Daoud M, Kirby B, et al. Clinicopathologic correlation of
hypocomplementemic and normocomplementemic urticarial vasculitis. J. Amer. Acad.
Dermatol., 1998; 38:899-905.

Complimentary Contributor Copy